Company
Silo Pharma, Inc. (SILO)
Standardized SEC financial data for Silo Pharma, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001514183 · NASDAQ · Pharmaceutical Preparations.
Revenue growth (YoY)
0.0%
Return on equity
-67.0%
Free cash flow
-$4.7M
Current ratio
11.36×
EPS (diluted)
$-0.50
Ratios for fiscal year 2025, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $41K | — | $72K | $72K | $72K | $72K |
| Cost of revenue |
Balance sheet
| USD | FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | — | $9.8M | $11.4M | $3.5M | $3.9M | $4.7M |
| Accounts receivable |
Cash flow
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$2.3M | -$3.5M | -$3.2M | — | -$3.8M | -$4.7M |
| Investing cash flow |
Get SILO data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/SILO/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/SILO/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"